These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2387381)

  • 41. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA; Vincent AC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Brevikarin dihydrochloride--a new original anti-arrhythmia agent].
    Denisenko PP; Vinogradova TV; Semenov AA
    Farmakol Toksikol; 1988; 51(2):50-3. PubMed ID: 3378605
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The effect of dalargin on the course of experimental cardiac arrhythmias].
    Grekova TI; Reznikov KM; Vinokurova OV; Kireeva AA; Taratinova TI; Nikolaevskiĭ VA; Shchetinkina NA
    Eksp Klin Farmakol; 1994; 57(2):24-6. PubMed ID: 8205043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative antiarrhythmic actions of encainide and its major metabolites.
    Gomoll AW; Byrne JE; Mayol RF
    Arch Int Pharmacodyn Ther; 1986 Jun; 281(2):277-97. PubMed ID: 3092755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of bonnecor on blood coagulability and thrombocyte aggregation in transient myocardial ischemia].
    Denisova SV; Sapozhkov AV
    Eksp Klin Farmakol; 1992; 55(6):29-31. PubMed ID: 1305870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The cardiotoxic properties of anti-arrhythmia agents].
    Spasov AA; Gurova NA
    Eksp Klin Farmakol; 1997; 60(2):20-3. PubMed ID: 9206561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride.
    Alexanian AR; Arutyunian NS; Galoyan AA
    Arzneimittelforschung; 1996 Dec; 46(12):1110-3. PubMed ID: 9006783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiarrhythmic activity of cetiedil and its analogues.
    Haring J; Mesangeau D; Huet Y; Aurousseau M
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):467-81. PubMed ID: 6110633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The effect of ecdysterone on experimental arrhythmias and changes in the hemodynamics and myocardial contractility induced by coronary artery occlusion].
    Kurmukov AG; Ermishina OA
    Farmakol Toksikol; 1991; 54(1):27-9. PubMed ID: 1860493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antifibrillatory effect of tetrahydroberberine.
    Sun AY; Li DX
    Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):301-5. PubMed ID: 8249620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiarrhythmic effects of LR-A/113 a new calcium antagonistic drug.
    Stella L; de Novellis V; Vacca C; Guarino A; Cantoni V; Fici F; Rossi F
    Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):235-48. PubMed ID: 8884994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The anti-arrhythmia properties of thymogen].
    Reznikov KM; Vinokurova OV; Alabovskiĭ VV; Vinokurov AA
    Eksp Klin Farmakol; 1994; 57(6):31-3. PubMed ID: 7756955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
    Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
    Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrophysiological effects of a new antiarrhythmic substance Bonnecor (AWD 19-166, GS 015) on mammalian myocardium.
    Nilius B; Schüttler K; Benndorf K; Boldt W
    Pharmazie; 1985 Dec; 40(12):847-51. PubMed ID: 3841600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Anti-arrhythmic properties of specific bradycardic agents from the group of 2-mercaptobenzimidazole derivatives].
    Chichkanov GG; Tsorin IB; Kirsanova GIu; Berdiaev SIu; Turilova AI
    Eksp Klin Farmakol; 1997; 60(5):35-9. PubMed ID: 9483403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Local anesthetic and antiarrhythmic effect of some imidazolidin-2-one derivatives.
    Librowski T; Filipek B; Czarnecki R
    Acta Pol Pharm; 2000; 57(5):391-6. PubMed ID: 11126032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The anti-arrhythmic activity of the arylamides of alpha-hexamethyleneiminocarboxylic acids].
    Berdiaev SIu; Turilova AI; Lebedeva AS; Likhosherstov AM; Ninidze IG; Kaverina NV; Skoldinov AP
    Farmakol Toksikol; 1991; 54(3):32-4. PubMed ID: 1915816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiarrhythmic and hemodynamic effects of prifuroline.
    Benharkate M; Plassard G; Legeai J; Worcel M
    Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Some aspects of the antiarrhythmic effect of glialin].
    Khisatmutdinova RIu; Baschenko NZh; Zarudiĭ FS; Gabdrakhmanova SF; Makara NS; Sapozhnikova TA
    Eksp Klin Farmakol; 2006; 69(3):26-8. PubMed ID: 16878494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.